Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage I or Stage II Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of AP23573 in Patients With Relapsed or Refractory Hematologic Malignancies (8669-024)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Motexafin Gadolinium for the Treatment of Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Dose-Escalating Study Of SB-485232 Administered Intravenously Every 28 Days To Adults With Solid Tumors Or Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
LMB-2 Immunotoxin in Treating Young Patients With Relapsed or Refractory Leukemia or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases
- Status
- UNKNOWN
- Phase
- PHASE2
Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent Primary CNS Lymphoma
- Status
- COMPLETED
- Phase
- NA
Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients
- Status
- COMPLETED
- Phase
- NA
LMP2a-Specific Cytotoxic T-Lymphocytes, Lymphoma (ACDAL)
- Status
- TERMINATED
- Phase
- PHASE1
Avastin Plus Rituximab for Patients With B-Cell Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Alemtuzumab in Treating Patients With Waldenstrom's Macroglobulinemia
- Status
- WITHDRAWN
- Phase
- PHASE2
T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Rituximab, Carmustine; Cytarabine, Etoposide, & Melphalan; Stem Cell Transplantation for Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- NA
Anti-Tac(Fv)-PE38 (LMB-2) to Treat Cutaneous T-Cell Lymphomas
- Status
- COMPLETED
- Phase
- PHASE2
Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3